Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-0711
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii? ; volume:15 ; number:1 ; day:24 ; month:2 ; year:2016 ; pages:1-6 ; date:12.2016
Annals of clinical microbiology and antimicrobials ; 15, Heft 1 (24.2.2016), 1-6, 12.2016
- Creator
-
Demirdal, Tuna
- Contributor
-
Sari, Ummu Sena
Nemli, Salih Atakan
SpringerLink (Online service)
- DOI
-
10.1186/s12941-016-0123-7
- URN
-
urn:nbn:de:1111-201602254246
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Demirdal, Tuna
- Sari, Ummu Sena
- Nemli, Salih Atakan
- SpringerLink (Online service)
Other Objects (12)
Colistin Therapy in a 23-Week Gestational-Age Neonate with Multidrug-Resistant Acinetobacter baumannii Pneumonia
Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients?
Efficacy of adjunctive inhaled colistin and tobramycin for ventilator-associated pneumonia: systematic review and meta-analysis
Deep odontogenic infections—identifying risk factors for nosocomial pneumonia
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
Update of the treatment of nosocomial pneumonia in the ICU
Microbiological analysis of nosocomial pneumonia at Tanta University Chest Hospital
Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes
Risk factors for progression to bacteremia among patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia in the Intensive Care Unit
Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia
Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients
Prediction of methicillin-resistant Staphylococcus aureusin patients with non-nosocomial pneumonia
Colistin Therapy in a 23-Week Gestational-Age Neonate with Multidrug-Resistant Acinetobacter baumannii Pneumonia
Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients?
Efficacy of adjunctive inhaled colistin and tobramycin for ventilator-associated pneumonia: systematic review and meta-analysis
Deep odontogenic infections—identifying risk factors for nosocomial pneumonia
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
Update of the treatment of nosocomial pneumonia in the ICU
Microbiological analysis of nosocomial pneumonia at Tanta University Chest Hospital
Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes
Risk factors for progression to bacteremia among patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia in the Intensive Care Unit
Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia
Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients
Prediction of methicillin-resistant Staphylococcus aureusin patients with non-nosocomial pneumonia
Colistin Therapy in a 23-Week Gestational-Age Neonate with Multidrug-Resistant Acinetobacter baumannii Pneumonia
Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients?
Efficacy of adjunctive inhaled colistin and tobramycin for ventilator-associated pneumonia: systematic review and meta-analysis
Deep odontogenic infections—identifying risk factors for nosocomial pneumonia
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
Update of the treatment of nosocomial pneumonia in the ICU
Microbiological analysis of nosocomial pneumonia at Tanta University Chest Hospital
Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes
Risk factors for progression to bacteremia among patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia in the Intensive Care Unit
Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia
Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients